How to buy Neovasc stock | $0.68

Neovasc Inc is a medical devices business based in the US. Neovasc shares (NVCN) are listed on the NASDAQ and all prices are listed in US Dollars. Neovasc employs 71 staff and has a trailing 12-month revenue of around 0.00.

Neovasc stock price (NASDAQ: NVCN)

Use our graph to track the performance of NVCN stocks over time.

Neovasc shares at a glance

• Key figures

Information last updated 2021-10-18.

Latest market close	$0.68
52-week range	$0.66 - $2.55
50-day moving average	$0.74
200-day moving average	$0.84
Wall St. target price	$1.88
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.84

Buy Neovasc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Neovasc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Neovasc price performance over time

Historical closes compared with the close of $0.68 from 2021-10-15

1 week (2021-10-11)	-1.45%
1 month (2021-09-17)	-9.33%
3 months (2021-07-16)	-15.00%
6 months (2021-04-16)	-15.00%

1 year (2020-10-16)	-73.02%
2 years (2019-10-18)	-81.62%
3 years (2018-10-18)	2.2
5 years (2016-10-18)	31.55%

Neovasc financials

Revenue TTM	$2.2 million
Gross profit TTM	$-1,983,378
Return on assets TTM	-58.53%
Return on equity TTM	-91.85%
Profit margin	0%
Book value	$0.94
Market capitalisation	$46.4 million

TTM: trailing 12 months

Shorting Neovasc shares

There are currently 516,036 Neovasc shares held short by investors – that's known as Neovasc's "short interest". This figure is 47.6% down from 984,483 last month.

There are a few different ways that this level of interest in shorting Neovasc shares can be evaluated.

Neovasc's "short interest ratio" (SIR)

Neovasc's "short interest ratio" (SIR) is the quantity of Neovasc shares currently shorted divided by the average quantity of Neovasc shares traded daily (recently around 456669.02654867). Neovasc's SIR currently stands at 1.13. In other words for every 100,000 Neovasc shares traded daily on the market, roughly 1130 shares are currently held short.

However Neovasc's short interest can also be evaluated against the total number of Neovasc shares, or, against the total number of tradable Neovasc shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Neovasc's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Neovasc shares in existence, roughly 10 shares are currently held short) or 0.0091% of the tradable shares (for every 100,000 tradable Neovasc shares, roughly 9 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Neovasc.

Find out more about how you can short Neovasc stock.

Neovasc share dividends

We're not expecting Neovasc to pay a dividend over the next 12 months.

Have Neovasc's shares ever split?

Neovasc's shares were split on a 1:10 basis on 1 July 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Neovasc shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Neovasc shares which in turn could have impacted Neovasc's share price.

Neovasc share price volatility

Over the last 12 months, Neovasc's shares have ranged in value from as little as $0.66 up to $2.55. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neovasc's is 2.9566. This would suggest that Neovasc's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Neovasc overview

Neovasc Inc. , a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc.

Frequently asked questions

What percentage of Neovasc is owned by insiders or institutions?
Currently 20.93% of Neovasc shares are held by insiders and 12.189% by institutions. How many people work for Neovasc?
Latest data suggests 71 work at Neovasc. When does the fiscal year end for Neovasc?
Neovasc's fiscal year ends in December. Where is Neovasc based?
Neovasc's address is: 13562 Maycrest Way, Richmond, BC, Canada, V6V 2J7 What is Neovasc's ISIN number?
Neovasc's international securities identification number is: CA64065J3047 What is Neovasc's CUSIP number?
Neovasc's Committee on Uniform Securities Identification Procedures number is: 64065J106